Pain Response and Acute Hematologic Toxicity in Castration-Resistant Prostate Cancer (CRPC) patients (pts) treated with Ra-223-dichloride: a Single-Center Clinical Series

MLA

Follacchio, Ga, et al. Pain Response and Acute Hematologic Toxicity in Castration-Resistant Prostate Cancer (CRPC) Patients (Pts) Treated with Ra-223-Dichloride: A Single-Center Clinical Series. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3686..8646263757204c19987de35eea473746&authtype=sso&custid=ns315887.

APA

Follacchio, G., Frantellizzi, V., Liberatore, M., Monteleone, F., & De Vincentis, G. (2016). Pain Response and Acute Hematologic Toxicity in Castration-Resistant Prostate Cancer (CRPC) patients (pts) treated with Ra-223-dichloride: a Single-Center Clinical Series.

Chicago

Follacchio, Ga, V Frantellizzi, M Liberatore, F Monteleone, and G De Vincentis. 2016. “Pain Response and Acute Hematologic Toxicity in Castration-Resistant Prostate Cancer (CRPC) Patients (Pts) Treated with Ra-223-Dichloride: A Single-Center Clinical Series,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3686..8646263757204c19987de35eea473746&authtype=sso&custid=ns315887.